Group empowerment and training (GREAT) for diabetes has already been implemented in this setting and additional bespoke sessions on insulin initiation could be added.27 Another innovation during COVID-19 was telehealth support for people with poorly controlled T2DM and affected with COVID-19.28 A similar service could support patients during the initiation of insulin. This evidence concerns the gene INS and type 2 diabetes mellitus.